SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 11.67 |
| Enterprise Value ($M) | 12.00 |
| Book Value ($M) | -5.95 |
| Book Value / Share | -0.11 |
| Price / Book | -1.96 |
| NCAV ($M) | -8.80 |
| NCAV / Share | -0.17 |
| Price / NCAV | -1.33 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -0.93 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.21 |
| Current Ratio | 0.21 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2.21 |
| Assets | 5.06 |
| Liabilities | 11.01 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.58 |
| Operating Income | -17.25 |
| Net Income | -44.54 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -15.84 |
| Cash from Investing | -0.36 |
| Cash from Financing | 6.26 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Halpern John D | 9.60 | 16.26 | |
| 13G | Konar Shameek | 5.50 | ||
| 13G/A | Freebird Partners LP | 9.90 | 20.92 | |
| 13G/A | Iaf, Llc | 5.20 | 21.51 | |
| 13D/A | Cherington Charles | 32.80 | 22.78 | |
| 13G/A | Singer Nicholas Jason | 4.92 | 327.16 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 81,184 | 412,893 | 19.66 | |
| 200,518 | 668,582 | 29.99 | |
| 69,773 | 343,540 | 20.31 | |
| 37,822 | 71,710 | 52.74 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ENVB – Enveric Biosciences, Inc. | EPIX – ESSA Pharma Inc. |
| EQ – Equillium, Inc. | ESLA – Estrella Immunopharma, Inc. |
| EVOK – Evoke Pharma, Inc. |
Financial data and stock pages provided by
Fintel.io